secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001558370-24-000669
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta realigns into three segments and provides historical recast data
-----------------------------------------------------------------------

- Effective Oct 1, 2023, Azenta restructured into Multiomics, Sample Management Solutions, and B Medical Systems.
- Multiomics offers genomic analysis, gene sequencing, and gene synthesis under a single business unit.
- Sample Management Solutions combines Sample & Repository, Ultracold Systems, and Consumables & Instruments.
- Historical segment data for FY2023 and FY2022 recast to reflect the new structure are provided in Exhibit 99.1.
- No specific financial numbers are available in the filing text; recast data requires review of the exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000155837024000669/0001558370-24-000669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000155837024000669/azta-20240131x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer